Halma plc (OTCMKTS:HLMAF) Short Interest Up 1,312.1% in January

Halma plc (OTCMKTS:HLMAF) was the target of a large increase in short interest in January. As of January 31st, there was short interest totalling 872,700 shares, an increase of 1,312.1% from the January 15th total of 61,800 shares. Based on an average daily volume of 217,000 shares, the days-to-cover ratio is presently 4.0 days.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on HLMAF shares. Citigroup raised Halma to a “hold” rating in a report on Thursday, November 28th. Hsbc Global Res cut shares of Halma from a “hold” rating to a “moderate sell” rating in a research note on Thursday, February 6th. Berenberg Bank raised shares of Halma from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, January 22nd. Finally, Redburn Atlantic upgraded Halma to a “strong-buy” rating in a research report on Monday, November 4th.

Halma Trading Down 0.1 %

HLMAF traded down $0.03 during trading on Wednesday, hitting $36.03. The company’s stock had a trading volume of 2,080 shares, compared to its average volume of 80,991. Halma has a one year low of $26.82 and a one year high of $38.53. The business’s 50 day simple moving average is $35.01 and its 200-day simple moving average is $33.83. The company has a quick ratio of 1.85, a current ratio of 2.72 and a debt-to-equity ratio of 0.42.

Halma Dividend Announcement

The company also recently announced a dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 20th were paid a dividend of $9.00 per share. This represents a yield of 0.82%. The ex-dividend date of this dividend was Thursday, December 19th.

About Halma

Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Medical.